Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer

N Engl J Med. 2019 Mar 7;380(10):985-986. doi: 10.1056/NEJMc1900150.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Albumins
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Humans
  • Paclitaxel
  • Triple Negative Breast Neoplasms*

Substances

  • 130-nm albumin-bound paclitaxel
  • Albumins
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • atezolizumab
  • Paclitaxel